# GLP-1 Seller State Coverage: Who Publishes Where They Ship | This GLP A census of which GLP-1 sellers publish the states they serve, how many states those lists cover, and why an absent list is not a coverage claim. Publisher: This GLP Editorial Team Canonical: https://thisglp.com/research/who-publishes-the-states-they-serve Updated: 2026-10-26 Published: 2026-09-16 [← Research](https://thisglp.com/research) Formats # GLP-1 Seller State Coverage: Who Publishes Where They Ship Publishing the states served costs nothing and cannot go stale. A count of how many GLP-1 sellers publish a state list, and how wide the ones that do reach. [This GLP Editorial Team](https://thisglp.com/about)September 20265 min readUpdated September 2026 580 sellers: who says where they ship · 201 publish a list · 379 do not · Of those that do: · 50 states or more · 110 · 40 to 49 · 33 · 20 to 39 · 18 · 2 to 19 · 27 · a single state · 13 **Research, not medical advice.** This GLP is independent and educational. Nothing here is a substitute for individualized care from a licensed clinician, and reading it creates no doctor–patient relationship. Talk to your own provider before starting, stopping, or changing any medication, peptide, or therapy. See our [methodology](https://thisglp.com/methodology) and [terms](https://thisglp.com/terms). ## Key takeaways - 379 of 580 sellers on this roster publish no list of the states they serve — 65% of them. - Of the 201 that do publish one, the median is 50 states. - 110 of them reach 50 or more; 40 reach fewer than twenty. - A seller absent from this count has not been shown to serve nowhere. It has been shown not to have written it down. - Corpus read most recently October 2026. Whether a seller can legally ship to your address is the first question that matters and one of the last most storefronts answer. It is also the cheapest possible disclosure — a list of states costs nothing to publish and cannot go stale in an interesting way — which makes the silence worth counting. It sits alongside the other silences in [what sellers will not tell you](https://thisglp.com/research/what-glp1-sellers-do-not-publish). ## How many say Of 580 sellers this site can rank, 201 publish a list of states and 379 do not. That is 65% of the market giving no answer to the question a reader has to resolve before any price matters. Silence is not a coverage claim ⛔ A seller in the 379 has not been shown to serve nowhere, or to serve everywhere. It has been shown not to have published the list. Several of them almost certainly ship nationally and simply never wrote it down. That distinction matters because this site has already found the opposite error made three times elsewhere — an unrecorded field read as a recorded negative, about named businesses. A census of what is missing is only honest if it keeps saying what missing means. ## How wide the ones that answer reach Among the 201 sellers that publish a list, the median is 50 states, and 110 of them reach 50 or more. Publication and breadth travel together: a seller with near-national coverage has an easy thing to say, and says it. The tail is the more interesting end. 40 sellers publish a list covering fewer than twenty states, and 13 serve a single state. Those are the ones for whom the disclosure costs something — it disqualifies most readers immediately — and they make it anyway, which is worth crediting rather than penalizing. ## What to do with it Check coverage before price, not after. A cheaper seller that cannot ship to you is not a cheaper seller, and a storefront that will not say is a storefront you have to ask — which means finding someone to ask, and most of this market publishes nothing about that either, as listed in [the questions they leave open](https://thisglp.com/tools/questions-they-leave-open). The state-by-state view of who has said they serve where is in [coverage by state](https://thisglp.com/tools/coverage-by-state), and the wider question of which figures survive contact with a real purchase is in [when the headline is not the bill](https://thisglp.com/research/glp1-advertised-vs-billed-corrections). [Contour Health](https://thisglp.com/reviews/contour-health) publishes a concrete exclusion list in its [FAQ](https://www.contourhealthrx.com/faqs): Arkansas, Kentucky, Michigan and Mississippi. That is more useful for an initial shortlist than a general nationwide claim. It remains a provider statement, not independent license verification or a promise that an individual prescription will be approved. ## Frequently asked How many sellers publish a state list? The count is derived on the page when it builds. A large number of sellers give no answer at all to the question a reader has to resolve before any price is relevant. Does a missing list mean the seller cannot ship to me? No. It means the seller has not written the answer down. Several of them almost certainly ship nationally and never published it. How wide are the ones that do publish? The median is fifty states, and most of them reach fifty or more. A handful serve fewer than twenty, and a few serve one. ## Sources ## Where to get it ### Best GLP-1 injections Every injectable seller we can verify, with the price each one publishes and an honest read of what the trials measured. [Compare providers →](https://thisglp.com/best/compounded-semaglutide) ## More in Formats - [ Label-approved sites and semaglutide exposure · Abdomen · 2 in. from navel · similar · Thigh · under the skin · similar · Upper arm · under the skin · similar · Blood levels, not weight loss. No trial randomized people to a site. ### Where Should You Inject Ozempic? Abdomen, Thigh or Arm Gave the Same Exposure ](https://thisglp.com/research/where-should-you-inject-ozempic) - [ The labeled ladder — four weeks on every rung · 0.25 · wk 1–4 · 0.5 · wk 5–8 · 1 · wk 9–12 · 1.7 · wk 13–16 · 2.4 · wk 17+ · Milligrams weekly. No compounded product carries this label. ### Semaglutide Starting Dose: 0.25 mg, and What Compounding Changes ](https://thisglp.com/research/semaglutide-starting-dose) - [ Approved: weight management, US, April 2026 · Phase 3 in progress, not approved: · sleep apnea · hypertension · urinary incontinence · osteoarthritis pain · artery disease · A daily tablet, not a peptide, not an injection. ### Is There a GLP-1 Pill That Works? Two Tablets, Two Different Answers ](https://thisglp.com/research/does-the-glp1-pill-work-as-well-as-the-injection)